You have 9 free searches left this month | to do more
Showing 1 - 25 of
122 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Not yet recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
2021-07-02
Jul 2, 2021
L
Not yet recruiting
  • Multiple Myeloma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
2021-05-13
May 13, 2021
C
Recruiting
  • Multiple Myeloma
  • Selinexor (80mg/d)
  • +4 more
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
2021-06-07
Jun 7, 2021
T
Recruiting
  • Safety and Efficacy
  • JWCAR129
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
2020-12-16
Dec 16, 2020
G
Completed
  • Relapse/Refractory Multiple Myeloma
    • Patra, Greece
      Ag.Andreas General Hospital
    2021-05-10
    May 10, 2021
    S
    Active, not recruiting
    • Plasma Cell Myeloma
    • isatuximab SAR650984
    • +2 more
    • San Francisco, California
    • +4 more
    2021-09-20
    Sep 20, 2021
    O
    Active, not recruiting
    • Renal Impairment
    • RRMM
    • Brno, Czechia
    • +15 more
    2021-07-08
    Jul 8, 2021
    S
    Recruiting
    • Neoplasm Malignant
    • Duarte, California
    • +6 more
    2021-09-29
    Sep 29, 2021
    T
    Recruiting
    • RRMM
    • CAR-T therapy in Relapsed/Refractory multiple myeloma
    • Lishui, Zhejiang, China
    • +2 more
    2020-11-16
    Nov 16, 2020
    S
    Completed
    • Plasma Cell Myeloma
    • Isatuximab SAR650984
    • +2 more
    • Scottsdale, Arizona
    • +12 more
    2021-07-08
    Jul 8, 2021
    O
    Active, not recruiting
    • Multiple Myeloma
    • Melphalan flufenamide (Melflufen)
    • +3 more
    • Boston, Massachusetts
    • +15 more
    2021-07-09
    Jul 9, 2021
    S
    Recruiting
    • Plasma Cell Myeloma Refractory
    • Isatuximab SAR650984
    • +4 more
    • Birmingham, Alabama
    • +16 more
    2021-10-29
    Oct 29, 2021
    C
    Completed
    • Multiple Myeloma
    • Pomalidomide and Dexamethasone
    • Linz, Austria
    • +21 more
    2021-08-25
    Aug 25, 2021
    I
    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • (no location specified)
    2018-09-22
    Sep 22, 2018
    O
    Active, not recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +104 more
    2021-11-17
    Nov 17, 2021
    K
    Recruiting
    • Multiple Myeloma
    • Lymphoma
    • CM313-Dose escalation
    • +3 more
    • Beijing, Beijing, China
    • +2 more
    2021-11-11
    Nov 11, 2021
    C
    Active, not recruiting
    • Multiple Myeloma
    • Renal Impairment
    • 4 mg Oral POM + 40 mg Oral DEX
    • 2 mg Oral POM + 40 mg Oral DEX
    • Denver, Colorado
    • +8 more
    2021-05-04
    May 4, 2021
    S
    Recruiting
    • Plasma Cell Myeloma
    • isatuximab SAR650984
    • +3 more
    • Little Rock, Arkansas
    • +55 more
    2021-11-16
    Nov 16, 2021
    G
    Active, not recruiting
    • Multiple Myeloma
    • Belantamab mafodotin frozen liquid
    • Belantamab mafodotin lyophilized powder
    • New Haven, Connecticut
    • +58 more
    2021-09-30
    Sep 30, 2021
    G
    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • San Francisco, California
    • +5 more
    2021-10-01
    Oct 1, 2021
    U
    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Aurora, Colorado
      University of Colorado Hospital
    2021-10-25
    Oct 25, 2021
    T
    Recruiting
    • Multiple Myeloma in Relapse
      • Duarte, California
      • +5 more
      2021-01-20
      Jan 20, 2021
      S
      Recruiting
      • Plasma Cell Myeloma
      • Duarte, California
      • +13 more
      2021-09-19
      Sep 19, 2021